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Abstract: This article provides a brief review of the pathophysiology of osteoarthritis and the
ontogeny of chondrocytes and details how physical exercise improves the health of osteoarthritic
joints and enhances the potential of autologous chondrocyte implants, matrix-induced autologous
chondrocyte implants, and mesenchymal stem cell implants for the successful treatment of damaged
articular cartilage and subchondral bone. In response to exercise, articular chondrocytes increase their
production of glycosaminoglycans, bone morphogenic proteins, and anti-inflammatory cytokines and
decrease their production of proinflammatory cytokines and matrix-degrading metalloproteinases.
These changes are associated with improvements in cartilage organization and reductions in
cartilage degeneration. Studies in humans indicate that exercise enhances joint recruitment of
bone marrow-derived mesenchymal stem cells and upregulates their expression of osteogenic and
chondrogenic genes, osteogenic microRNAs, and osteogenic growth factors. Rodent experiments
demonstrate that exercise enhances the osteogenic potential of bone marrow-derived mesenchymal
stem cells while diminishing their adipogenic potential, and that exercise done after stem cell
implantation may benefit stem cell transplant viability. Physical exercise also exerts a beneficial
effect on the skeletal system by decreasing immune cell production of osteoclastogenic cytokines
interleukin-1β, tumor necrosis factor-α, and interferon-γ, while increasing their production of
antiosteoclastogenic cytokines interleukin-10 and transforming growth factor-β. In conclusion,
physical exercise done both by bone marrow-derived mesenchymal stem cell donors and recipients
and by autologous chondrocyte donor recipients may improve the outcome of osteochondral
regeneration therapy and improve skeletal health by downregulating osteoclastogenic cytokine
production and upregulating antiosteoclastogenic cytokine production by circulating immune cells.
Keywords: exercise; osteoarthritis; osteoporosis; mesenchymal stem cells; hematopoietic stem cells;
stem cell transplantation; chondroblasts; chondrocytes; cytokines

1. Introduction
In the global burden of disease 2010 study, osteoarthritis accounted for 17,135 years of life lived
with disability (YLDs), an increase of 64% when compared to YLDs of 1990. Overall, musculoskeletal
disorders (which included inflammatory causes of arthritis) accounted for 6.8% of total YLDs [1],
with osteoarthritis ranked as the 11th leading cause of disability worldwide [2]. The global prevalence of
osteoarthritis is expected to increase as the average age and weight of the world’s population increases.
Physical exercise has long been recognized as an essential factor in the maintenance of
skeletal health, particularly during adolescence, when ~50% of bone mass accretion occurs [3].
The 2019 American College of Rheumatology/Arthritis Foundation guidelines for the management
of osteoarthritis of the hip and knee emphasized the importance of regularly performed physical
exercise [4]. Both traditional (resistance, aerobic, and flexibility) and non-traditional (tai chi, yoga,
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and aquatic) exercises have been shown to be effective in the management of knee and hip
osteoarthritis [5]. In their systematic review of 44 clinical trials involving patients with knee
osteoarthritis, Fransen and associates found that land-based therapeutic exercises reduced pain
and improved physical function and the quality of life for at least 2–6 months after the cessation of
formal treatment [6]. In this regard, the World Health Organization recommends that adult men and
women should accumulate at least 150 min of moderate intensity physical exercise per week and young
people aged 5–17 years should accumulate at least 60 min of physical exercise of moderate to vigorous
intensity daily [7].
There is increasing interest in treating articular cartilage and subchondral bone defects and
osteoarthritis with autologous chondrocyte implants (ACIs), matrix autologous chondrocyte implants
(MACIs), and bone marrow-derived mesenchymal cell implants or injections [8–14]. ACI and MACI
procedures have been shown to produce durable long-term outcomes in the treatment of partial and
full-thickness articular cartilage defects in tibiofemoral joints [15–19]. In addition, mesenchymal stem
cells mobilized to joints from the peripheral blood or placed on implantation matrices have the potential
to repair cartilage by differentiating into chondrocytes [20].
In this article, I review the pathophysiology of osteoarthritis and detail how physical exercise
improves the health of articular cartilage and chondrocytes in osteoarthritis and enhances the potential
of mesenchymal stem cells and chondrocytes for successful implantation therapy. I discuss how
exercise protects the skeletal system by upregulating the production of antiosteoclastogenic cytokines
and downregulating the production of osteoclastogenic cytokines by chondrocytes and peripheral
blood mononuclear cells. A summary of scaffolds currently approved or undergoing clinical trials
for MACI and exercise protocols that can be used to rehabilitate osteoarthritis patients and recipients
of chondrocyte and mesenchymal stem cell implants is provided. I also provide an aerobic exercise
protocol that can be used to condition tissue donors.
2. Materials and Methods
This narrative review is on exercise as an adjuvant to cartilage regeneration therapy. The research
strategy included the following: 1. defining key topics; 2. identifying key words or synonyms
that represent each of the key topics; 3. an online PubMed search of key topics and key
words; and 4. a refinement of the search based on initial findings. The search included all reviews,
meta-analyses, and clinical trials on key topics published between the years 2000 and 2020.
Restricted were review articles with identical samples and identical outcomes, identical samples
with different outcomes, increased samples and identical outcomes, and decreased samples with
identical outcomes. Key topics included osteoarthritis, exercise and osteoarthritis, stem cells, stem cell
implants, exercise and stem cells, mesenchymal stem cells, mesenchymal stem cell implants, exercise and
mesenchymal stem cells, hematopoietic stem cells, hematopoietic stem cell implants, exercise and
hematopoietic stem cells, chondrocytes, chondrocyte implants, autologous chondrocyte implantation,
matrix-induced autologous chondrocyte implantation, exercise and chondrocytes, osteoclastogenic
cytokines, exercise and osteoclastogenic cytokines, implantation scaffolds, antiosteoclastogenic
cytokines and exercise, and antiosteoclastogenic cytokines. Keywords included exercise, osteoarthritis,
osteoporosis, stem cells, mesenchymal stem cells, hematopoietic stem cells, chondrocytes,
osteoclastogenic cytokines, and antiosteoclastogenic cytokines.
3. Definition of Exercise
In this article, the author has used the following definition of exercise: a physical activity that
involves repetitive voluntary contractions of limb, back, or abdominal muscles that are of sufficient
force to maintain or improve physical conditioning.
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4. Pathophysiology of Osteoarthritis
Osteoarthritis (OA) is a complex polygenetic disease involving structural and functional alterations
of the entire joint, including the articular cartilage, menisci, subchondral bone, capsule, synovium,
ligaments, and periarticular muscles. The knee is the most common joint to be involved, followed by
the hand and hip. OA is especially prevalent in the elderly, particularly elderly women, in overweight
individuals, and in persons with traumatic joint injuries, including those that are work related
(e.g., lifting of heavy loads, constant knee bending). The contribution of genetics in OA is estimated to
be between 40–80%, with late onset OA being associated with many common DNA variants [21].
OA is an ongoing process involving mechanical, inflammatory, and metabolic derangements of
the articular cartilage, subchondral bone, and synovium. This is reflected in the finding of elevated
blood levels of C-reactive protein (CRP) and picogram amounts of the proinflammatory cytokines
tumor necrosis factor (TNF)-α, interleukin (IL)-6, and IL-1β in OA that are present early in the disease
and proportionate to the patients’ symptoms and, in the case of TNF-α, in keeping with radiographic
findings of OA [22].
Articular cartilage primarily comprises tissue fluid, which accounts for 65–85% of its mass,
and type II collagen and proteoglycans, which account for 15–22% and 4–7% of its mass, respectively.
Proteoglycans include the small leucine-rich decorin, lumican, biglycan, fibromodulin, lumican,
and epiphycan, and the heparin sulfate proteoglycan perlecan. Other collagens (types V, VI, IX, X,
XI, XII, IV), cell adhesins, growth factors, and cytokines are also present. The predominant cell in
articular cartilage is the chondrocyte, which is responsible for maintaining articular homeostasis by
replacing degraded matrix with newly synthesized components [23]. In articular cartilage, synovium,
and synovial fluid, mesenchymal stem cells are also present and may serve as a valuable source of
stem cell transplantation in the treatment of OA [24].
Osteoarthritis is characterized by early alterations in the organization and molecular
composition of the articular cartilage extracellular matrix. This change is met with a compensatory
proliferative response of chondrocytes and an increase in chondrocyte matrix synthesis. With time,
hypertrophied chondrocytes become senescent, a phenotype associated with the secretion of
proinflammatory cytokines and matrix-degrading proteases and a reduction in the secretion of
anti-inflammatory cytokines [25–27]; this, in turn, stimulates proliferative and proinflammatory
responses in adjacent synovium and periarticular bone, causing synovial hypertrophy and contributing
to the development of osteophytes. Subchondral bone turnover and angiogenesis is increased,
with consequent vascular invasion of the cartilage [21]. Senescent chondrocytes eventually undergo
apoptosis, terminating articular cartilage synthesis [25]. Other metabolic derangements involving
transforming growth factor (TGF)-β, fibroblast growth factor (FGF)-2, FGF-18, growth differentiation
factor (GDF)-5, and hypoxia-induced factor (HIF)-2a may also contribute to the pathogenesis of OA [23].
Studies on menisci, which contain multiple subpopulations of cells responsible for tissue repair
and maintenance (“fibrochondrocytes”) have shown that their production of IL-1 is elevated in OA
(109–288 pg/mL). IL-1 is a potent proinflammatory and osteoclastogenic cytokine whose effects on
menisci and articular cartilage are catabolic [28].
Studies in mice indicate that nuclear factor of activated T cells 1 (NFAT1), a member of the
NFAT transcription factors, plays a critical role in maintaining the anabolic functions of adult articular
chondrocytes by regulating their expression of matrix-degrading proteinases and proinflammatory
cytokines. Deletion of NFAT1 in adult mice results in a loss of type II collagen and aggrecan and an
over-expression of matrix-degrading proteases and proinflammatory cytokines; this is followed by
chondrocyte proliferation and hypertrophy, destruction of articular surfaces, osteophyte formation,
and exposure of subchondral bone—findings characteristic of OA [29]. Rodova and associates
determined that NFAT1 expression in articular cartilage is regulated epigenetically by histone
methylation [30]. The anabolic activity of chondrocytes is maintained by their secretion of growth
factors TGF-β, insulin-like growth factor (IGF)-1, FGF-2, FGF-18, GDF-5, and bone morphogenic
proteins (BMPs) (Figure 1).
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Dahlberg and involved 45 subjects who had undergone medial meniscus resection 3–5 years prior
to the study and were at risk of developing OA. Subjects underwent supervised exercise training
three times weekly for 4 months or were assigned to a noninterventional group. All subjects had the
glycosaminoglycan content of their knee cartilage assessed by delayed gadolinium-enhanced magnetic
resonance imaging. Exercise increased cartilage levels of glycosaminoglycan in proportion to the level
of physical activity [31].
In a similar study, Munukka and associates assessed the effects of 12 months of leisure time
physical activity on the glycosaminoglycan content of femoral cartilages in 76 post-menopausal women
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with knee OA using delayed gadolinium-enhanced magnetic resonance imaging. They also found that
exercise increased the amount of cartilage glycosaminoglycan [32].
Iijima and associates studied the effects of 2–4 weeks of treadmill walking in 24 male Wistar
rats with induced damage to their knee joints using micro-computed tomography, histology,
and immunohistochemistry analysis. They found that exercise prevented the progression of
post-traumatic bone and cartilage lesions and increased BMP-2 and BMP-6 expression in the joint
superficial zone chondrocytes [33].
Assis and associates studied the effects of aerobic exercise training on an experimental model of
knee osteoarthritis in 50 male Wistar rats. Twenty of the rats were trained on treadmills 3 days/week
at 16 m/min for 50 min/day for 8 weeks. The exercising and control rats were sacrificed, and their
knee joints assessed by histologic, morphometric, and immunohistochemical analysis. Compared to
the controls, exercising animals had a better pattern of cartilage organization and less cartilage
degeneration. Exercising animals also had lower chondrocyte nuclear or nucleolar expression of IL-1β,
caspase-3, and MMP-13, confirming the ability of aerobic exercise to downregulate proinflammatory
and proteolytic pathways in this model of OA [34].
6. Exercise and Mesenchymal Stem Cells
The author is using the International Society for Cell and Gene Therapy committee’s
recommendation that the acronym “MSC” be used for both mesenchymal stem cells and mesenchymal
stromal cells and that the MSC acronym be preceded by “BM” for bone marrow origin and “AD” for
adipose tissue origin [35].
6.1. Exercise Studies in Rodents
Liu et al. reported the effects of 8 weeks of treadmill exercise (60 min per day at 19.3 m/min,
5-degree incline) on the proliferative, differential, and apoptotic abilities of cultured femoral bone
marrow-derived mesenchymal stem cells (BM-MSCs). They found that exercise enhanced their
osteogenic potential and decreased their adipogenic potential (Figure 2) and posited that “BMSC
derived from exercised rats on early passage may be a good cell source for bone tissue engineering” [36].
Emmons et al. report that 15 and 60 min of treadmill exercise done by C57 BI/6 mice increased the
proliferative capacity of their bone marrow hematopoietic stem cells (BM-HSCs) and multipotential
HSC progenitors by 40–61%. They attribute these findings to a change in the BM-HSC secretome,
which included an upregulation of granulocyte colony-stimulating factor (G-CSF) and stem cell
factor (SCF) [37]. Bourzac et al. reviewed literature reports on the effects of physical exercise on MSC
proliferation, differentiation, and homing and found that the effects of exercise varied depending on the
exercise protocol and the tissue from which MSCs were obtained; they concluded that “the combination
of physical exercise and MSC engraftment improves neural, cartilage, and muscular tissue recovery,
but it is not clear whether the effects of MSCs and exercise are additive or synergistic” [38]. Ocarino et al.
studied the effects of exercise on BM-MSCs in osteopenic female Wistar rats with and without nitric
oxidase inhibition. BM-MSCs were isolated from their femurs and cultured in osteogenic medium for
7, 14, and 21 days, phenotyped, and analyzed for alkaline phosphatase, collagen synthesis, and the
formation of mineralized nodules. They found that exercise increased BM-MSC osteogenesis and that
inhibition of nitric oxide diminished their osteogenic response. They concluded that “nitric oxide
mediates the beneficial effects of physical activity upon MSCs osteogenic differentiation” [39]. Hell and
associates measured the effects of treadmill exercise on the osteogenic potential of BM-MSCs in young
and adult female Wistar rats by measuring cell viability, percentage of cells per field, mineralized nodular
number, and gene expression for telomerase reverse transcriptase (TERT), alkaline phosphatase (AP),
caspase 3, osteocalcin, collagen I, and sialoprotein. They found that exercise increased the differentiation
of BM-MSCs in both study groups, but the effect was greater in young animals than in adults [40].
Using mice, Wallace and associates measured the effects of 5 days of treadmill exercise (30 min/day) on
BM-MSCs and found that exercise increased their osteogenic potential [41]. Yamaguchi measured the
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autophagy-related gene 3 (ATG3) and Unc-like kinase gene (Ulk1) in M-CPCs. BMP2 and BMP6
were also upregulated. The authors concluded that exercise upregulated the differentiation and
apoptosis of BM-MSCs [44]. In a study involving 20 amateur runners, Valenti et al. assessed the
effects of running one-half of a marathon on the expression of microRNAs (miRNAs) in human
BM-MSCs incubated with pre- and post-exercise sera. They found that exercise upregulated the
expression of miRNAs promoting osteoblast differentiation, including miR-21-5p, miR-129-5p,
miR-378-5p, and miR-188-5p, while downregulating the expression of a miRNA that promotes
adipocyte differentiation (miRNA-188-5p). They also found that exercise upregulated the expression
of the osteogenic gene Runx2 [45]. Niemiro et al. studied the kinetics of progenitor cell mobilization
during 60 min of treadmill exercises (70% Vo2peak ) performed by seven men. They found that exercise
increased circulating levels of cysteine x cysteine (CXC) chemokine ligand (CXCL)-12 and SCF in
hematopoietic stem cells but not in BM-MSCs. They concluded that exercise may serve as a valuable
adjunct in the context of HSC transplants [46].
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8. Exercise and Osteoclastogenic and Antiosteoclastogenic Cytokines

In a before and after trial involving 43 healthy adults, Smith and associates measured the effect
of six months of combined aerobic, resistance, and flexibility exercises on the production of
osteoclastogenic cytokines (IL-1α, TNF-α), antiosteoclastogenic cytokines (TGF-β, IL-4, IL-10), and
cytokines with variable effects on osteoclastogenesis (interferon (IFN)-γ, IL-6) by cultured mitogenstimulated peripheral blood mononuclear cells (PBMCs). Serum markers of bone formation
(osteocalcin) and bone resorption (C-terminal telopeptides of type I collagen) were also measured.
Exercises done for 2.5 h a week on average attenuated the production of osteoclastogenic cytokines
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7.2. In Humans
Zhang et al. found that dynamic compression of the type that occurs with exercise increased the
expression of chondrogenic genes in cultures of human BM-MSCs [48]. Sumanasinghe and associates
seeded human BM-MSCs in 3D type I collagen matrices and subjected them to 0%, 10%, or 12% uniaxial
cyclic tensile strain at 1 Hz for 4 h/day for 7 or 14 days. They found that BMP2 mRNA expression
and BMP2 production were upregulated in the strain samples as compared to controls, indicating that
mechanical strain of the type associated with exercise can induce osteogenic differentiation of human
BM-MSCs [49] (Figure 4).
8. Exercise and Osteoclastogenic and Antiosteoclastogenic Cytokines
In a before and after trial involving 43 healthy adults, Smith and associates measured the effect of six
months of combined aerobic, resistance, and flexibility exercises on the production of osteoclastogenic
cytokines (IL-1α, TNF-α), antiosteoclastogenic cytokines (TGF-β, IL-4, IL-10), and cytokines with
variable effects on osteoclastogenesis (interferon (IFN)-γ, IL-6) by cultured mitogen-stimulated
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Santos et al.
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and TNF-α and increasing blood levels of IL-10 [52,53]. Similar results were reported by Yuan and
associates,10.
including
exercise-related
reductions in osteoclastogenic cytokines IL-1, IL-6, and TNF-α and
Rehabilitation
Protocols
10.1. For Osteoarthritis
There is no consensus on what constitutes an optimal rehabilitation exercise program for
patients with OA with the exception that regularly performed physical exercise should become a
lifetime commitment and should be done in sufficient volume to relieve pain and improve function.
In designing a rehabilitation program consideration should be given to exercises that simulate the
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exercise-related increases in antiosteoclastogenic cytokines IL-2, IL-10, IL-12, IL-13, IL-18, and IFN-γ [54].
In a study involving the effect of acute resistance knee exercise (25 sets of 10 repetitions at 60% of
one repetition maximum) in 12 women with knee OA, Helmark et al. found that exercise increased
intraarticular and perisynovial levels of the anti-inflammatory cytokine IL-10 as compared to levels
found in 13 non-exercising controls [55].
In summary, exercise upregulates PBMC production and serum levels of antiosteoclastogenic
cytokines and downregulates PBMC production and serum levels of osteoclastogenic cytokines. In one
study, exercise increased intra-articular and perisynovial levels of IL-10 in patients with knee OA.
9. Scaffolds
A variety of scaffolds are in development for use in MACI therapy, including hydrogels containing
type I collagen, hyaluronic acid, albumin, fibrin, agarose, or alginate, and composite scaffolds composed
of type I and type III collagen, hyaluronic acid and poly-glycolic acid, polyacetic acid, or polydioxanone.
Currently, clinical trial entry for osteochondral repair is only approved for a nanocomposite
three-layered collagen-hydroxyapatite scaffold, a poly (lactic-co-glycolic acid)-calcium-sulfate bilayer
scaffold, and an aragonite-based scaffold. There is emerging interest in scaffolds that can deliver genes
or gene carriers that upregulate the production of growth factors in articular cartilage and subchondral
bone [56].
10. Rehabilitation Protocols
10.1. For Osteoarthritis
There is no consensus on what constitutes an optimal rehabilitation exercise program for patients
with OA with the exception that regularly performed physical exercise should become a lifetime
commitment and should be done in sufficient volume to relieve pain and improve function. In designing
a rehabilitation program consideration should be given to exercises that simulate the type of muscle
activity that patients use in their daily routines. The American College of Sports Medicine (ACSM)
guidelines suggest that aerobic training should include a minimum of 150 min of moderate intensity
or 75 min of vigorous intensity aerobic exercise per week in bouts of at least 10 min. For resistance
training, two sessions per week, with two sets of 8 to 12 repetitions at a load of 60% to 70% of
one repetition maximum with a rest period of ≥ 48 h between resistance training sessions are
indicated. Resistance training can produce favorable responses independent of the type of equipment
(dynamometers, weights, bands) utilized, the type of exercise (e.g., isokinetic, isotonic), and the muscle
action (i.e., isometric, eccentric concentric) performed [57].
10.2. For Post-Transplant Rehabilitation
In their comprehensive review of postoperative procedures used to rehabilitate matrix-induced
autologous chondrocyte implants of the tibiofemoral joint, Edward and associates concluded that
allowing patients to bear full weight at 6 weeks post-operation allowed a quicker return to normal
activity. Their review included 6-, 8-, 10-, and 12-week rehabilitation programs, all of which began
with two weeks of 20% weight bearing coupled with continuous passive motion (CPM) of 0–40 degree
knee flexion exercises starting 12–24 h post-surgery [58]. Upon full recovery from transplant surgery,
applying the ACSM exercise guidelines for rehabilitation of osteoarthritis would seem appropriate.
11. Pre-Implantation Exercises
For healthy donors of bone marrow-derived MSCs the author recommends prescribing an aerobic
exercise regimen using the following guidelines: 1. Calculate the patient’s age-based maximum heart
rate (MHR) using the following formula: MHR = 220 − age. 2. Start the exercise program at 40–50% of
MHR with weekly increments until the patient reaches 75–85% of MHR. The exercises should be done
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≥ 30 min/day, 5 days/week. This exercise formula may also be useful in setting aerobic exercise goals
in OA patients and in patients with implants following their period of rehabilitation.
12. Discussion
Mesenchymal stem cells are fibroblast-like cells that arise from embryonic mesenchyme and
serve as the source of bone, cartilage, tendon, and adipose tissue. In addition to bone marrow and
peripheral blood, MSCs are found in the vascular niches of adipose tissue, skeletal and cardiac muscle,
lung, cartilage, and tendons. These progenitor cells synthesize and secrete a number of growth factors,
extracellular matrix proteins, and cytokines that support the growth and survival of hematopoietic stem
cells. They are identified by their expression of cell surface markers CD73, CD90, and CD105 and the
absence of hematopoietic markers CD14 and CD45. Other defining criteria for MSCs include evidence
of clonal expansion and/or the capacity to differentiate into multiple cell types, including tendon,
cartilage, bone, and adipose tissue. MSCs represent a small fraction of the mononuclear cell population
in bone marrow (0.001–0.01%) [59].
At present, implant techniques used to treat knee OA include third-generation scaffold
implantations and chondrocyte and MSC injectable techniques. Importantly, methods using biomaterials
that incorporate chondroprogenitors, chondrocytes, and MSCs have led to significant progress in
regenerating OA joints. Scaffold implantation has produced a hyaline-like cartilage repair, durable pain
and function improvement, and no donor site morbidity. BM-MSC injections have resulted in pain and
functional improvement but have limited evidence of efficacy [11].
There is an emerging interest in developing scaffolds using viral and nonviral vectors that deliver
genes or gene products that stimulate the production of growth factors by articular chondrocytes and
subchondral bone. These growth factors include TGF-β, IGF-1, BMPs (particularly BMP-2 and BMP-7),
and FGF-2. The use of transcription factors to promote osteochondral healing, including Sox5, Sox6, Sox9,
Runx2, and Osx is planned, as well as the use of mRNAs [56]. It is reassuring that physical exercise and
strain studies have been shown to achieve similar goals, including the upregulation of the expression of
osteochondral genes and transcription factors (Runx2, Osx, MSx1, SPP-1, Sox9, COL2A1, ATG3, and Ulk1),
mRNAs encoding ALP, BMP2, BMP4, OCL, and collagen I, and the production of osteochondral end
products including TERT, ALP, caspase3, osteocalcin, BMP2, and BMP6 (see Figures 2–4).
In light of the beneficial effects of exercise on articular cartilage chondrocytes and on the
BM-MSC expression of osteochondral genes, transcription factors, and products, it is anticipated
that exercise will improve the results of ACIs and MACIs in patients with osteochondral defects.
ACIs involve an arthroscopic biopsy of a small piece of articular cartilage taken from an area not
subjected to major pressure, culturing the chondrocytes and injecting them into the diseased joint of the
donor/recipient [56]; in MACIs, the chondrocytes are incorporated into a scaffold matrix and placed in
the osteochondral defect during an open procedure. Preclinical trials have shown that both ACIs and
MACIs are successful in producing hyaline-like cartilage regrowth [60–63] with reasonable long-term
durability [64]. However, ACIs are associated with up to 40% dedifferentiation of chondrocytes during
culturing and/or after the transplant [65]. Whether exercise will improve this aspect of ACIs is yet to
be determined.
Whether other joint preservation techniques are benefitted by exercise is also to be determined.
Osteoplasty involves the drilling or punching of holes through the subchondral plate at the site
of the chondral defect; this incites an inflammatory response which includes the mobilization of
BM-MSCs to the articular surface [66]. Since exercise has been shown to increase circulating levels of
BM-MSCs, exercise done before and after osteoplasty has the potential to improve the results of this
regenerative technique.
The evidence provided in this review supports a policy of recommending physical exercise for
autologous chondrocyte donors/recipients and BM-MSC donors and recipients. In the author’s view,
patients with OA and recipients of osteochondral implants should make a lifetime commitment to
perform physical exercise in keeping with ACSM guidelines.
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Recommending exercise for patients undergoing regenerative procedures has the added
benefit of reducing their risks for ischemic cardiovascular disease, hypertension, diabetes mellitus,
metabolic syndrome, and certain forms of cancer [67].
13. Conclusions
Physical exercise done both by bone marrow-derived mesenchymal stem cell donors
and recipients and by autologous chondrocyte donor/recipients may improve the outcome of
osteochondral regeneration therapies and improve skeletal health by downregulating the production
of osteoclastogenic cytokines and upregulating the production of antiosteoclastogenic cytokines.
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